SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 25 | -97.5% | 0.00% | -100.0% |
| Q4 2015 | $39,000 | +21.9% | 1,000 | 0.0% | 0.02% | +11.1% |
| Q3 2015 | $32,000 | +6.7% | 1,000 | 0.0% | 0.02% | +5.9% |
| Q2 2015 | $30,000 | +11.1% | 1,000 | -50.0% | 0.02% | +112.5% |
| Q1 2015 | $27,000 | +92.9% | 2,000 | +100.0% | 0.01% | 0.0% |
| Q4 2014 | $14,000 | -33.3% | 1,000 | 0.0% | 0.01% | -38.5% |
| Q3 2014 | $21,000 | -30.0% | 1,000 | 0.0% | 0.01% | -27.8% |
| Q2 2014 | $30,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |